直觉外科(ISRG)
搜索文档
This 14.3% Dividend Could Double In Trump 2.0
Forbes· 2025-01-09 23:14
PHOENIX, ARIZONA - DECEMBER 22: U.S. President-elect Donald Trump smiles during Turning Point USA's ... [+] AmericaFest at the Phoenix Convention Center on December 22, 2024 in Phoenix, Arizona. The annual four day conference geared toward energizing and connecting conservative youth hosts some of the country's leading conservative politicians and activists. (Photo by Rebecca Noble/Getty Images)Getty ImagesIntuitive Surgical (ISRG) is an intriguing everything-proof stock for Trump 2.0. The company specializ ...
This Healthcare Stock Could Become a Major Artificial Intelligence (AI) Player
The Motley Fool· 2025-01-06 19:00
Investors looking to benefit from the exciting artificial intelligence (AI) market are likely to turn to the tech sector first. It's an understandable strategy. That's where many, if not most, of the prominent AI leaders operate. However, there are exciting companies in other industries that are quietly incorporating AI into their businesses and could eventually become leaders.One such corporation in the healthcare industry is Intuitive Surgical (ISRG 2.15%). Let's discuss the robotic-assisted surgery (RAS) ...
Intuitive Announces Executive Leadership Changes to Support Continued Global Growth
GlobeNewswire· 2025-01-03 22:15
Three executive vice president promotions strengthen core company strategic leadershipSUNNYVALE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced executive leadership promotions in support of the company’s continued global growth in pursuit of its mission to advance minimally invasive care. Henry Charlton has been promoted to the role of executive vice president and chief comm ...
Intuitive Surgical, Inc. (ISRG) Rises As Market Takes a Dip: Key Facts
ZACKS· 2024-12-27 08:06
公司表现 - 公司股票在最近交易日收盘价为53883美元,较前一交易日上涨034%,表现优于标普500指数的下跌004% [1] - 公司股票在过去一个月内下跌028%,表现优于医疗行业的下跌431%,但落后于标普500指数的上涨105% [6] - 公司预计在即将发布的财报中每股收益为176美元,同比增长10%,营收预计为221亿美元,同比增长1453% [2] - 公司年度每股收益预计为688美元,同比增长2049%,营收预计为815亿美元,同比增长1436% [9] 估值指标 - 公司当前PEG比率为418,高于医疗仪器行业平均的246 [4] - 公司当前远期市盈率为7806,远高于行业平均的2857,表明公司股票相对于行业处于溢价状态 [8] 行业分析 - 医疗仪器行业在Zacks行业排名中位列53,处于所有250多个行业的前22% [11] - Zacks行业排名显示,排名前50%的行业表现优于后50%的行业,比例为2比1 [5] 分析师评级 - 公司当前Zacks评级为3(持有),过去一个月内Zacks共识每股收益预期上调009% [10] - 分析师对公司的盈利预期调整与股价表现直接相关,积极的预期调整反映了分析师对公司业务和盈利能力的乐观态度 [3][7]
直觉外科:Q3增长强劲,DV5明年有望实现广泛推广
第一上海证券· 2024-12-13 15:19
直觉外科(ISRG) 更新报告 持有 2024 年 12 月 10 日 Q3 增长强劲,DV5 明年有望实现广泛推广 手术量高速增长,装机量持续提升: 公司 2024Q3 实现收入 20.4 亿元,同 比增长 17%。Q3 增速相比 Q2 进一步提升 2.5pts。其中,仪器与配件收入增长 18%至 12.6 亿美元。仅管减肥手术量在持续下降,且韩国医生罢工对韩国地 区手术量产生了较大影响,但得益于美国地区普外科以及日本、德国、法 国、英国等地区手术量的高速增长,总体手术量同比增速达到18%。系统收入 增长 17%至 4.45 亿美元。公司于 2024Q3 共安装了 379 台达芬奇手术系统,相 比 2023Q3 增加 67 台。2024 年 3 月推出的 DV5 延续了强劲的表现,继 Q2 安装 70 台后,Q3 安装量进一步提升至 110 台。此外,ION 系统也实现了 58 的安装 量。截止 2024 年 9 月 30 日。公司的达芬奇手术系统装机基数达到 9539 套, 较 2023Q3 末增加 15%。公司 Q3 Non-GAAP 归母净利润 6.69 亿美元,同比增长 28%。 DV5 计划 20 ...
Intuitive Surgical (ISRG) Upgraded to Buy: Here's What You Should Know
ZACKS· 2024-12-04 02:06
Investors might want to bet on Intuitive Surgical, Inc. (ISRG) , as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Individual inves ...
Intuitive Surgical Is Breaking Ground
Seeking Alpha· 2024-11-20 01:46
关于Intuitive Surgical公司 - Intuitive Surgical在加利福尼亚州破土动工建设新的大型总部同时继续构建其手术系统组合并扩展达芬奇手术系统[2] - 有分析师对Intuitive Surgical股票持有多头头寸通过股票所有权期权或其他衍生品[3] 关于The Retirement Forum - 提供可行的理念高收益安全退休投资组合和宏观经济展望以帮助最大化资本和收入并搜索整个市场来帮助最大化回报[1] 关于The Value Portfolio - 专门构建退休投资组合并采用基于事实的研究策略来识别投资包括大量阅读10K文件分析师评论市场报告和投资者报告并投资自己推荐的股票[2]
Is Intuitive Surgical (ISRG) Outperforming Other Medical Stocks This Year?
ZACKS· 2024-11-18 23:41
核心观点 - 公司Intuitive Surgical, Inc. (ISRG) 和 Atossa Genetics Inc. (ATOS) 是医疗行业中表现优异的股票,值得投资者关注 [1][6] 公司表现 - 公司ISRG年初至今的回报率为56.4%,远超医疗行业平均的-1.3% [4] - 公司ISRG在医疗行业中排名第3,属于Zacks Sector Rank中的16个行业组之一 [2] - 公司ISRG的Zacks Rank为2 (Buy),表明其具有在未来一到三个月内跑赢市场的潜力 [3] - 公司ISRG的全年度盈利共识估计在过去一个季度中提高了4.3%,显示出分析师情绪的改善和积极的盈利前景 [3] - 公司ISRG所属的医疗仪器行业年初至今平均增长3.2%,而ISRG的表现优于该行业 [5] - 公司ATOS年初至今的回报率为45.5%,同样表现优异 [4] - 公司ATOS的当前年度EPS共识估计在过去三个月中增加了6%,且其Zacks Rank也为2 (Buy) [5] 行业表现 - 医疗行业目前排名Zacks Sector Rank的第3位,涉及1024家公司 [2] - 医疗仪器行业包含86只个股,目前排名Zacks Industry Rank的第59位 [5]
Will ISRG Stock Continue Its Uptrend After Gaining 9.9% in a Month?
ZACKS· 2024-11-12 22:10
Shares of Intuitive Surgical (ISRG) have risen 9.9% in the past month against the Zacks Medical - Instruments industry’s decline of 1% and the broader Zacks Medical sector’s fall of 3.2%. The S&P 500 Index has returned 2.6% in the same period. ISRG stock has risen 58.8% year to date, primarily due to strong demand for its robotic surgery procedures.In the third quarter of 2024, ISRG reported a 17% year-over-year revenue growth, reaching $2 billion. This growth was driven by higher procedure volumes, expansi ...
ISRG Stock To $5,000
Forbes· 2024-10-26 19:00
文章核心观点 - 公司的机器人手术业务正在颠覆医疗行业,有望实现长期10倍增长 [1] - 公司拥有领先的技术和市场地位,在机器人手术市场占据主导地位 [5] - 公司的高毛利和净利率有望进一步提升,未来可能实现年收入175亿美元,利润550亿美元 [6] 根据相关目录分别进行总结 公司的机器人手术业务优势 - 可以最小化手术过程中的人为错误 [3] - 可以减少手术并发症,缩短患者恢复时间 [3] - 公司的机器人手术系统已获FDA批准,受到医院青睐 [5] - 公司的机器人手术系统可以执行多种类型的手术 [5] 市场空间和发展潜力 - 全球每年有超过3亿例手术,如果机器人手术系统能占据一半市场,将达到1.5亿例 [2] - 某些医院已有15%以上的手术采用机器人系统 [2] - 公司每台机器人手术系统每年可产生约66万美元的经常性收入 [4] - 如果公司占据半数机器人手术市场,可实现年收入175亿美元,利润550亿美元 [6] 竞争格局 - 公司在机器人手术市场领先,主要竞争对手产品尚未获FDA批准 [5] - 医院更倾向于使用公司的机器人手术系统,因为医生已经过培训 [5]